Showing results (81-90 of 90) with videos related to

Sort By:
Pageof 9
You have reached the last page of results.This site can display upto 90 results.
Brain : a Journal of Neurology|November 23, 2019
Genetic modifiers of risk and age at onset in GBA associated Parkinson's disease and Lewy body dementiaCornelis Blauwendraat, Xylena Reed, Lynne Krohn, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|January 9, 2020
Genetic screening of a large series of North American sporadic and familial frontotemporal dementia casesEliana Marisa Ramos, Deepika Reddy Dokuru, Victoria Van Berlo, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|January 9, 2020
Utility of the global CDR<sup>®</sup> plus NACC FTLD rating and development of scoring rules: Data from the ARTFL/LEFFTDS ConsortiumToji Miyagawa, Danielle Brushaber, Jeremy Syrjanen, et al.
JAMA Neurology|March 17, 2025
Automated Imaging Differentiation for ParkinsonismDavid E Vaillancourt, Angelos Barmpoutis, Samuel S Wu, et al.
Alzheimer'S & Dementia (Amsterdam, Netherlands)|December 25, 2019
Nonlinear Z-score modeling for improved detection of cognitive abnormalityJohn Kornak, Julie Fields, Walter Kremers, et al.
Nature Aging|May 16, 2025
Large-scale network analysis of the cerebrospinal fluid proteome identifies molecular signatures of frontotemporal lobar degenerationRowan Saloner, Adam M Staffaroni, Eric B Dammer, et al.
Neurology|April 8, 2021
Plasma Neurofilament Light for Prediction of Disease Progression in Familial Frontotemporal Lobar DegenerationJulio C Rojas, Ping Wang, Adam M Staffaroni, et al.
Neuron|May 3, 2024
Genome sequence analyses identify novel risk loci for multiple system atrophyRuth Chia, Anindita Ray, Zalak Shah, et al.
Acta Neuropathologica|May 28, 2019
A nonsynonymous mutation in PLCG2 reduces the risk of Alzheimer's disease, dementia with Lewy bodies and frontotemporal dementia, and increases the likelihood of longevitySven J van der Lee, Olivia J Conway, Iris Jansen, et al.
Acta Neuropathologica|January 20, 2020
Correction to: A nonsynonymous mutation in PLCG2 reduces the risk of Alzheimer's disease, dementia with Lewy bodies and frontotemporal dementia, and increases the likelihood of longevitySven J van der Lee, Olivia J Conway, Iris Jansen, et al.
Pageof 9